Human medicines European public assessment report (EPAR): Elucirem, gadopiclenol, Date of authorisation: 07/12/2023, Revision: 4, Status: Authorised

Human medicines European public assessment report (EPAR): Vueway, gadopiclenol, Date of authorisation: 07/12/2023, Revision: 4, Status: Authorised

Human medicines European public assessment report (EPAR): Tecartus, brexucabtagene autoleucel, Date of authorisation: 14/12/2020, Revision: 17, Status: Authorised

Human medicines European public assessment report (EPAR): Yescarta, axicabtagene ciloleucel, Date of authorisation: 23/08/2018, Revision: 22, Status: Authorised

Human medicines European public assessment report (EPAR): Forxiga, dapagliflozin, Date of authorisation: 11/11/2012, Revision: 33, Status: Authorised

Human medicines European public assessment report (EPAR): Lenalidomide Krka (previously Lenalidomide Krka d.d. Novo mesto), lenalidomide, Date of authorisation: 11/02/2021, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR): Quviviq, daridorexant, Date of authorisation: 29/04/2022, Revision: 11, Status: Authorised

Herbal medicinal product: Zingiberis rhizoma, Zingiber officinale Roscoe, F: Assessment finalised

Herbal medicinal product: Trigonellae foenugraeci semen, Trigonella foenum-graecum  L., F: Assessment finalised

Human medicines European public assessment report (EPAR): Eliquis, apixaban, Date of authorisation: 18/05/2011, Revision: 39, Status: Authorised